MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events

J To, M Davis, A Sbrana, B Alderman, D Hui… - Supportive Care in …, 2023 - Springer
Background Approximately 18% of patients with cancer use cannabis at one time as
palliation or treatment for their cancer. We performed a systematic review of randomized …

Perineural invasion in pancreatic ductal adenocarcinoma: from molecules towards drugs of clinical relevance

F Selvaggi, E Melchiorre, I Casari, S Cinalli, M Cinalli… - Cancers, 2022 - mdpi.com
Simple Summary A few types of cancers are currently as challenging and difficult to defeat
as pancreatic ductal adenocarcinoma. Several reasons contribute to the complexity of this …

Synergistic interactions of cannabidiol with chemotherapeutic drugs in mcf7 cells: Mode of interaction and proteomics analysis of mechanisms

MA Alsherbiny, DJ Bhuyan, MN Low, D Chang… - International journal of …, 2021 - mdpi.com
Cannabidiol (CBD), a nonpsychoactive phytocannabinoid, has recently emerged as a
potential cytotoxic agent in addition to its ameliorative activity in chemotherapy-associated …

Unmet needs of 1210 Chinese breast cancer survivors and associated factors: a multicentre cross-sectional study

X Bu, C Jin, R Fan, ASK Cheng, PHF Ng, Y Xia, X Liu - BMC cancer, 2022 - Springer
Abstract Background Breast cancer survivors (BCSs) often have potential unmet needs.
Identification of the specific needs of BCSs is very significant for medical service provision …

Retrospective Observational Study on the Characteristics of Pain and Associated Factors of Breakthrough Pain in Advanced Cancer Patients

R Fan, X Li, S Yang, X Bu, Y Chen… - Pain Research and …, 2022 - Wiley Online Library
Objective. This study aimed to conduct a retrospective observational study to understand the
status of characteristics of pain and identify potential variables influencing the clinical …

An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina

N Fernández, MG Cappello, PN Quiroga - Forensic Science International, 2023 - Elsevier
In recent years, the therapeutic use of cannabis products, especially cannabis oils, has
increased significantly, due to the pharmacological potential of their cannabinoids, for the …

Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know

A Gorzo, A Havași, Ș Spînu, A Oprea, C Burz… - Journal of Clinical …, 2022 - mdpi.com
Pain is a highly debilitating emotional and sensory experience that significantly affects
quality of life (QoL). Numerous chronic conditions, including cancer, are associated with …

Clinical research evidence supporting administration and dosing recommendations of medicinal cannabis as analgesic in cancer patients

C Christensen, M Allesø, M Rose, C Cornett - Journal of Clinical …, 2022 - mdpi.com
The analgesic potential of Cannabis sativa L.—based medicinal cannabis products for
treatment of cancer associated chronic pains has gained increased interest in recent years …

Cannabis medicinal y cáncer: beneficios en dolor oncológico y otros síntomas relacionados

M Herrero-Trujillano - Revista de la Sociedad Española del Dolor, 2022 - SciELO Espana
El cannabis tiene el potencial de modular algunos de los síntomas más prevalentes en el
cáncer, ya sean derivados del propio tumor o de los tratamientos antitumorales. Sin …

[HTML][HTML] Evidencia científica actualizada del tratamiento con cannabis medicinal en pacientes con dolor crónico

JF García-Henares… - Revista de la Sociedad …, 2022 - SciELO Espana
El cannabis medicinal ha sido promovido por los medios de comunicación y por la opinión
pública en general. La planta del cannabis y los medicamentos a base de cannabis (CbM) …